Brain Monitors to Reduce Child Confusion After Anesthesia
The Role of BIS-Guided Anesthesia in Reducing Emergence Delirium in Children (Çocuklarda Derlenme Deliryumunun Azaltılmasında BİS Kılavuzluğunda Anestezi)
1 other identifier
interventional
125
1 country
1
Brief Summary
The goal of this clinical trial was to learn if using a brain monitor to adjust anesthesia (sleep medicine) during surgery could prevent emergence delirium (severe confusion and agitation upon waking) in children aged 2 to 12 years having their tonsils or adenoids removed. The main questions it aimed to answer were: Did using a brain monitor lower the chance of children waking up confused and upset? Did using the brain monitor reduce the amount of anesthesia gas (sevoflurane) needed during surgery, and did it affect recovery time or pain levels? Researchers compared anesthesia adjusted using a bispectral index (BIS) brain monitor to anesthesia adjusted using standard care to see if the brain monitor lowered the chance of emergence delirium. Participants in the study: Received general anesthesia (a standardized mix of inhaled and intravenous medicines, including sevoflurane and fentanyl) to safely sleep through surgery to remove their tonsils or adenoids Had the dose of their main anesthesia gas (sevoflurane) adjusted during surgery based on either brain monitor readings (targeting a specific sleep depth of 40-60) or standard physical responses (like heart rate and blood pressure) Were checked by the research team immediately after waking up to measure their confusion, agitation, and pain using standard clinical rating scales
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 8, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 21, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 21, 2025
CompletedFirst Submitted
Initial submission to the registry
August 4, 2026
CompletedFirst Posted
Study publicly available on registry
September 17, 2026
CompletedSeptember 17, 2026
September 1, 2026
4 months
August 4, 2026
September 15, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Primary Outcome Measure 1: Incidence of Emergence Delirium Assessed by the PAED Scale
Evaluated postoperatively using the Pediatric Anesthesia Emergence Delirium (PAED) scale. The scale ranges from a minimum of 0 to a maximum of 20. Higher scores mean a worse outcome (more severe delirium). Scores of 10 or higher were classified as a positive diagnosis for emergence delirium.
Postoperative minutes 5, 10, 15, 30, 45, and 60 following extubation.
Primary Outcome Measure 2: Incidence of Emergence Delirium Assessed by the Watcha Scale
Evaluated postoperatively using the Watcha behavioral scale. The scale ranges from a minimum of 1 to a maximum of 4. Higher scores mean a worse outcome (greater agitation and delirium). Scores of 3 to 4 were classified as a positive diagnosis for emergence delirium.
Postoperative minutes 5, 10, 15, 30, 45, and 60 following extubation.
Primary Outcome Measure 3: Incidence of Emergence Delirium Assessed by the Cravero Scale
Evaluated postoperatively using the Cravero behavioral scale. The scale ranges from a minimum of 1 to a maximum of 5. Higher scores mean a worse outcome (greater agitation). Scores of 4 or higher were classified as a positive diagnosis for emergence delirium.
Postoperative minutes 5, 10, 15, 30, 45, and 60 following extubation.
Secondary Outcomes (4)
Total Sevoflurane Consumption
Intraoperative (From anesthesia induction until the completion of surgery).
Postoperative Pain Assessed by the FLACC Scale
Postoperative minutes 5, 10, 15, 30, 45, and 60 following extubation.
Rescue Opioid Usage
Up to 60 minutes during the post-anesthesia recovery period.
Recovery Time
Up to 4 hours (From transfer to the recovery unit until discharge criteria were successfully met).
Study Arms (2)
BIS-Guided Anesthesia
EXPERIMENTALThis group received the specific intervention (the BIS monitor to guide anesthesia depth) that is the main focus of your research study.
Standard Care Anesthesia
ACTIVE COMPARATORThis group received the standard, established method of care (titrating anesthesia based on heart rate and blood pressure).
Interventions
Anesthetic depth was continuously guided by the Bispectral Index (BIS) monitor. A single-use BIS sensor was placed on the patient's forehead before anesthesia induction to record real-time EEG activity. The primary inhaled anesthetic (sevoflurane) was continuously titrated throughout the surgery to strictly maintain a BIS value within the target range of 40 to 60. If the BIS value dropped below 40, the sevoflurane concentration was decreased. If the BIS value exceeded 60, the continuous remifentanil infusion (0.02-0.1 mcg/kg/min) was increased first, followed by an increase in sevoflurane if necessary. Intervention
Anesthetic depth was guided solely by traditional clinical signs and autonomic responses. The primary inhaled anesthetic (sevoflurane) was initiated at a 1% end-tidal concentration and adjusted in 0.25% increments (range 0.50% to 1.5%) to maintain the patient's heart rate and blood pressure within ±25% of their baseline pre-anesthesia values. Remifentanil was also infused continuously (0.02-0.1 mcg/kg/min) and adjusted based on clinical requirements. A BIS sensor was attached to the patient to record data, but the monitor screen was completely blinded to the anesthesia care provider, ensuring titration relied exclusively on standard hemodynamic metrics.
Eligibility Criteria
You may qualify if:
- Children between the ages of 2 and 12 years
- Scheduled for a planned surgery to remove adenoids, tonsils, or both
- Generally healthy or having only mild medical conditions (American Society of Anesthesiologists class I or II)
- Expected to have a surgery that lasts less than 4 hours
- Having the procedure as an outpatient and expected to go home the same day
You may not qualify if:
- Having severe medical conditions (American Society of Anesthesiologists class III or IV)
- Having a known history of neurological or psychiatric diseases
- Diagnosed with a developmental delay
- Having severe heart, lung, or metabolic conditions
- Having a known allergy to any of the medications used in the study
- Parents or legal guardians refuse to provide written consent to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Baskent University
Ankara, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- This was a single-blind clinical trial. Participants and their guardians were masked to the study arm assignment. Anesthesia care providers could not be masked to the intervention assignment itself, as they were required to actively titrate the anesthesia based on the assigned method. However, a specific masking protocol was used for the active comparator group to prevent bias. In the standard care group, the BIS monitor was applied to the patient to record data, but the screen was completely covered. This ensured the care provider remained masked to the actual BIS values during the surgery, forcing them to rely solely on standard hemodynamic-guided titration.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 4, 2026
First Posted
September 17, 2026
Study Start
August 8, 2025
Primary Completion
November 21, 2025
Study Completion
November 21, 2025
Last Updated
September 17, 2026
Record last verified: 2026-09